Concordant with others, the authors observed that patients with cHCC-CC were more likely to have higher serum AFP levels, background liver disease, were more often males and <60 years of age, compared to those with ICC [11,20,41,95]. The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.